Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Development of a Chimeric Protein BiPPB-mIFNγ-tTβRII for Improving the Anti-Fibrotic Activity in Vivo by Targeting Fibrotic Liver and Dual Inhibiting the TGF-β1/Smad Signaling Pathway.
Protein J. 2023 Dec;42(6):753-765. doi: 10.1007/s10930-023-10147-z. Epub 2023 Sep 10.
Protein J. 2023.
PMID: 37690089
PDGFβ receptor-targeted delivery of truncated transforming growth factor β receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-β1/Smad signaling pathway.
Wang B, Wang X, Dong Y, Liu X, Xu L, Liu Y, Wu Y, Wang C, Liu H.
Wang B, et al.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):237-252. doi: 10.1007/s00210-023-02594-3. Epub 2023 Jul 4.
Naunyn Schmiedebergs Arch Pharmacol. 2024.
PMID: 37401970
Item in Clipboard
Cite
Cite